Table 1.
ADAM 10 |
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Immunoreactivity |
|||||||||||
Variables | 0 | + | ++ | +++ | P-value | Location in the cell | |||||
Normal epidermis (n = 5) | 2 | 3 | 0 | 0 | Cytoplasm | ||||||
Differentiation | Well differentiated CSCC (n = 12) | 4 | 4 | 4 | 0 | *0.368 | Cytoplasm | ||||
Moderately differentiated CSCC (n = 7) | 0 | 3 | 4 | 0 | *0.021 | Cytoplasm | |||||
Poorly differentiated CSCC (n = 7) | 0 | 2 | 2 | 3 | *0.014 | Cytoplasm | |||||
Total (n = 26) | 4 | 9 | 10 | 3 | *.0045 | – | |||||
**0.017 | |||||||||||
ADAM 17 | |||||||||||
Immunoreactivity | |||||||||||
Variables | 0 | + | ++ | +++ | P-value | Location in the cell | |||||
Normal epidermis (n = 5) | 1 | 4 | 0 | 0 | Cytoplasm | ||||||
Differentiation | Well differentiated CSCC (n = 12) | 2 | 2 | 4 | 4 | *0.063 | Cytoplasm & Nucleus | ||||
Moderately differentiated CSCC (n = 7) | 0 | 2 | 5 | 0 | * 0.015 | Cytoplasm & Nucleus | |||||
Poorly differentiated CSCC (n = 7) | 0 | 2 | 4 | 1 | * 0.017 | Cytoplasm & Nucleus | |||||
Total (n = 26) | 2 | 6 | 13 | 5 | * 0.012 | – | |||||
**0.093 |
a; ADAM 10, 17 positivity: +, weakly positive (1–20%); ++, moderately positive (21–50%), and +++, strongly positive (>50 %)
compared with normal epidermis
compared among 3 differentiated CSCC